QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 233 filers reported holding QIAGEN NV in Q2 2018. The put-call ratio across all filers is 4.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,472,000 | +2.9% | 57,742 | 0.0% | 0.76% | -20.5% |
| Q1 2020 | $2,402,000 | -84.0% | 57,742 | -87.0% | 0.95% | -75.4% |
| Q4 2019 | $14,971,000 | +2.5% | 442,942 | 0.0% | 3.87% | -4.9% |
| Q3 2019 | $14,604,000 | -18.7% | 442,942 | 0.0% | 4.07% | -20.1% |
| Q2 2019 | $17,961,000 | -0.3% | 442,942 | 0.0% | 5.10% | -14.8% |
| Q1 2019 | $18,019,000 | +18.1% | 442,942 | 0.0% | 5.98% | +10.5% |
| Q4 2018 | $15,259,000 | -9.1% | 442,942 | 0.0% | 5.41% | +8.0% |
| Q3 2018 | $16,779,000 | +4.8% | 442,942 | 0.0% | 5.01% | -0.3% |
| Q2 2018 | $16,017,000 | +11.9% | 442,942 | 0.0% | 5.03% | +14.3% |
| Q1 2018 | $14,311,000 | +30.1% | 442,942 | +24.5% | 4.40% | -0.7% |
| Q4 2017 | $11,003,000 | -1.8% | 355,742 | 0.0% | 4.43% | -6.8% |
| Q3 2017 | $11,206,000 | -6.1% | 355,742 | 0.0% | 4.75% | -15.4% |
| Q2 2017 | $11,928,000 | +15.7% | 355,742 | 0.0% | 5.61% | +3.8% |
| Q1 2017 | $10,306,000 | – | 355,742 | – | 5.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| C M BIDWELL & ASSOCIATES LTD | 301,504 | $8,448,000 | 1.99% |
| PRIMECAP MANAGEMENT CO/CA/ | 19,143,036 | $536,388,000 | 0.53% |
| Granahan Investment Management | 535,700 | $15,010,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1,704,116 | $47,749,000 | 0.37% |
| BALYASNY ASSET MANAGEMENT L.P. | 914,759 | $25,608,000 | 0.14% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 626,250 | $17,548,000 | 0.02% |
| BALYASNY ASSET MANAGEMENT L.P. | 153,700 | $4,303,000 | 0.02% |
| Capital Research Global Investors | 2,259,565 | $63,393,000 | 0.02% |
| RHUMBLINE ADVISERS | 201,388 | $5,643,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 16,373 | $459,000 | 0.01% |